Guillermo H. Giambartolomei

Also affiliated with Instituto de Química y Fisicoquímica Biológicas

VeterinaryImmunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A nanovaccine formulation of Chlamydia recombinant MOMP encapsulated in PLGA 85:15 nanoparticles augments CD4+ effector (CD44high CD62Llow) and memory (CD44high CD62Lhigh) T-cells in immunized mice”.

A nanovaccine formulation of Chlamydia recombinant MOMP encapsulated in PLGA 85:15 nanoparticles augments CD4+ effector (CD44high CD62Llow) and memory (CD44high CD62Lhigh) T-cells in immunized mice

Nanomedicine Nanotechnology Biology and Medicine(2020)10.1016/j.nano.2020.102257

N/A

0DataRank · unranked

29 citations

Saurabh Dixit, Richa Verma, Skyla A. Duncan, Mamie T. Coats, Guillermo H. Giambartolomei +3 more

Encapsulation of Recombinant MOMP in Extended-Releasing PLGA 85:15 Nanoparticles Confer Protective Immunity Against a Chlamydia muridarum Genital Challenge and Re-Challenge

Frontiers in Immunology(2021)10.3389/fimmu.2021.660932

N/A

0DataRank · unranked

10 citations

Saurabh Dixit, Richa Verma, Skyla A. Duncan, Lula Smith, Guillermo H. Giambartolomei +3 more

Effects of prime-boost strategies on the protective efficacy and immunogenicity of a PLGA (85:15)-encapsulated Chlamydia recombinant MOMP nanovaccine

Pathogens and Disease(2024)10.1093/femspd/ftae004

N/A

0DataRank · unranked

2 citations

Richa Verma, Timothy E. Egbo, Guillermo H. Giambartolomei, Shree R. Singh, Vida A. Dennis +1 more